about
The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleusThe metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF)N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancerThe role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygiumA novel sodium bicarbonate cotransporter-like gene in an ancient duplicated region: SLC4A9 at 5q31Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesisImportance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activityIdentification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors.Heparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: involvement of mitogen-activated protein kinase cascadesp53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascadesHeparin-binding EGF-like growth factor and ErbB signaling is essential for heart functionEpithelial sheet movement requires the cooperation of c-Jun and MAP3K1Protein tyrosine phosphatase, PTP1B, expression and activity in rat corneal endothelial cellsHeparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblastsRegulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinomaTargeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancementsMining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injuryGeneration and characterization of conditional heparin-binding EGF-like growth factor knockout mice.Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation.Heart valve development: endothelial cell signaling and differentiationAn EGFR autocrine loop encodes a slow-reacting but dominant mode of mechanotransduction in a polarized epithelium.A mouse model of otitis media identifies HB-EGF as a mediator of inflammation-induced mucosal proliferation.Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cellsTrafficking of epidermal growth factor receptor ligands in polarized epithelial cells.Skin wound healing and scarring: fetal wounds and regenerative restitution.Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway.Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.Infectious complications in head and neck cancer patients treated with cetuximab: propensity score and instrumental variable analysisHeparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy.Computational modeling of extracellular mechanotransduction.Calpains as potential anti-cancer targetsp53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop.The physiologic and therapeutic role of heparin in implantation and placentation.Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cellsHeparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cellsThe mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha.ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice.Differential effects of planktonic and biofilm MRSA on human fibroblasts.
P2860
Q24295651-45A73712-5AB4-4666-979F-09466051E223Q24534617-AB576F43-4207-4A5F-B449-D49250429E41Q24535534-012560C3-E952-4CB8-B8A2-F9AF3BBF61B3Q24564355-D62A2C37-DA1F-488C-987A-55318BF85D14Q24684329-823C809E-2C8F-4844-A31A-51827E61858AQ24797898-6240DD17-9924-471C-A85A-E2FCD7564056Q26852845-9E4A9C4F-A75C-4315-96A4-1E8210B49253Q28115248-AD220C91-22FF-471F-827F-655C77C60CE3Q28343200-0039CC55-3DCE-40BC-9CA3-5589598751EAQ28348018-E199C886-36CB-4A4F-8533-D13417CDE05AQ28362225-7A240BC4-E903-48CA-B9E0-6B9611994F30Q28505013-50A680C4-069A-48BA-8BBE-E1A444EF50F5Q28507451-42A26A1E-A7C4-407F-A5D8-6473EFE6A157Q28565792-E0180890-BE6F-4A5C-8E23-FE3FE526F122Q28580119-670141B1-B346-4D29-8C1D-F74FD9C40092Q28749302-3842390F-A982-4A2A-AE0B-9CDCA7C19893Q30393215-05D18F1C-201F-475F-A1CC-38F99F597C20Q30478475-01F23812-69E7-42D6-8463-0205998BFA0AQ30485976-38529DA0-029C-4387-9BD8-197B212F4315Q30835877-68397E85-BCD6-44E7-904E-CDB019511CF7Q33607338-783365C9-4BE9-435A-8A1F-716240EBFC34Q33890958-7575C833-7AB0-4687-B433-C05988AC2797Q33916488-0594FA04-B6E7-4396-B678-951C2BFE2C2FQ34027743-1793A9BD-1F76-42A7-800D-A7D57C5BD2ADQ34267140-76E5A5D4-9E16-4680-9AD5-7F0D0C10295EQ34383439-DEAF11C6-83B4-49E2-91E7-79C214B82C56Q34416270-38AF14E6-573A-453C-91A2-CAF836D92A26Q34448852-D985A68A-05DB-44D1-AEFF-EC41B589D401Q34499968-37EEF068-64EC-48F1-83AD-274E1C2596DCQ34516136-4F5E2F1B-74E4-4F97-B68B-C512F4AC7809Q34601046-109D24EF-EDA9-4F09-A2FB-0E584AD5FB65Q34793288-6C4E474A-6C74-4D73-AAC1-D1039A430CF9Q34794097-482A2B8B-87D8-4596-A2FE-400FD35D76BBQ35007371-D9A67FA9-E525-499E-8E61-84B147BDC5B3Q35032897-1C1687F8-B3DA-4191-BE0A-0AC7873F5C9BQ35099053-DF21BF4C-9986-4A04-B10A-42047C8DCC55Q35113673-66067D7B-37D9-4397-969C-53597B94C56FQ35129283-3E42571A-0A6E-47E9-9F85-CFC19D542A0FQ35747862-E0E7FE7B-3AA1-41F9-81AF-9478DB5E053BQ35798739-20C1EE7D-0119-4E65-8A50-1F8CF7A86F6C
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Heparin-binding EGF-like growth factor.
@ast
Heparin-binding EGF-like growth factor.
@en
Heparin-binding EGF-like growth factor.
@nl
type
label
Heparin-binding EGF-like growth factor.
@ast
Heparin-binding EGF-like growth factor.
@en
Heparin-binding EGF-like growth factor.
@nl
prefLabel
Heparin-binding EGF-like growth factor.
@ast
Heparin-binding EGF-like growth factor.
@en
Heparin-binding EGF-like growth factor.
@nl
P1476
Heparin-binding EGF-like growth factor.
@en
P2093
P304
P356
10.1016/S0304-419X(97)00024-3
P407
P577
1997-12-01T00:00:00Z